Physician profile
Umar Cheema
NPI 1164919437
$3,529.16
in general payments reported to CMS, 2019-2025
9 companies · $246 in 2025
The $246 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,823 · 2024: $1,461 · 2025: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,529.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,529.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,837.84 | 2023-2025 | Proclaim, Eterna |
| Nevro Corp. | $984.23 | 2023-2024 | Senza |
| Stratus Medical, LLC | $204.35 | 2023 | Nimbus |
| Boston Scientific Corporation | $195.73 | 2024 | Intracept |
| Medtronic, INC. | $156.64 | 2023-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Vanta Adaptivestim |
| Globus Medical, INC. | $65.82 | 2025 | Senza |
| Spr Therapeutics, INC | $31.39 | 2023 | Sprint Pns System |
| Avanos Medical | $29.98 | 2024 | Generator |
| Amgen INC. | $23.18 | 2024 | Evenity, Prolia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Umar Cheema listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.